New resources address the longevity gap for people living with mental illness
Mental health consumers and their treating clinicians will benefit from a comprehensive suite of resources, released today, that present evidence-based guidance for managing the physical health effects associated with severe mental health conditions.
$7 million gift to drive Mindgardens mood disorders research
May 16, 2023Businessman James Packer, with The Packer Family Foundation, has made a $7 million gift to establish the James Packer Chair in Mood Disorders at UNSW and the Mindgardens Neuroscience Network.
Leadership grant for Mindgardens nutrition researcher Dr Scott Teasdale
December 2, 2022Mindgardens Neuroscience Network congratulates Dr Scott Teasdale on his award of a five-year NHMRC Investigator Grant in the Emerging Leadership category,
A/Prof Jackie Curtis recognised for role in mental health reform
February 1, 2023The Executive Director of Mindgardens Neuroscience Network, A/Prof Jackie Curtis, is included in a new book that describes the contribution of female leaders in mental health reform in NSW.
Categories
Mindgarden News
View allOpinion: Pilot program, Keep Quitting in Mind, found one in nine people who smoke and have a severe mental illness quit the habit
April 16, 2024A smoking cessation pilot program Keep Quitting in Mind – designed specifically for people living with severe mental illness – has helped one in nine participants quit smoking, demonstrating the positive impacts that are possible for an at-risk yet typically overlooked population group.
Promising results for smoking cessation program as one in nine participants quit the habit
April 4, 2024A smoking cessation program, Keep Quitting in Mind (KQIM), for people living with mental illness has resulted in one in nine participants quitting the habit and many others reducing their daily smoking by half.
Study eases concern at antipsychotics use in pregnancy
March 18, 2024The use of antipsychotics during pregnancy isn’t linked to childhood neurodevelopmental disorders or learning difficulties, UNSW Sydney-led study shows – giving assurance to those concerned about continuing their medications during pregnancy.
NeuRA research reveals complex interplay of nature and nurture in emotion and cognition
February 15, 2024The way our brain processes different emotional and cognitive tasks may be underpinned by common factors, find scientists from Neuroscience Research Australia (NeuRA) and UNSW Sydney.
Anti-inflammatory drug found to help adults with severe schizophrenia
January 23, 2024Research conducted at Neuroscience Research Australia has found that an injection of an anti-flammatory biological known as Canakinumab in patients with schizophrenia and elevated inflammation brought about a decrease in psychotic symptom severity and inflammation. The research was published in Brain, Behavior, and Immunity.
Member News
View allLaunch of world-first guidelines for the treatment of first responders with PTSD
March 22, 2024Black Dog Institute and UNSW Sydney launched new guidelines for the management of PTSD among emergency service workers on Thursday, 21 March in NSW Parliament with Emergency Management Minister Jihad Dib and Mental Health Minister Rose Jackson.
Mental health training for your team? It’s good for everyone
March 20, 2024Investing in mental health training for your health professional team is good for staff and good for patients and clients — but what should health care organisations look for when choosing a training provider?
Study eases concern at antipsychotics use in pregnancy
March 18, 2024The use of antipsychotics during pregnancy isn’t linked to childhood neurodevelopmental disorders or learning difficulties, UNSW Sydney-led study shows – giving assurance to those concerned about continuing their medications during pregnancy.
NeuRA research reveals complex interplay of nature and nurture in emotion and cognition
February 15, 2024The way our brain processes different emotional and cognitive tasks may be underpinned by common factors, find scientists from Neuroscience Research Australia (NeuRA) and UNSW Sydney.
Anti-inflammatory drug found to help adults with severe schizophrenia
January 23, 2024Research conducted at Neuroscience Research Australia has found that an injection of an anti-flammatory biological known as Canakinumab in patients with schizophrenia and elevated inflammation brought about a decrease in psychotic symptom severity and inflammation. The research was published in Brain, Behavior, and Immunity.
Events
View allMindLabs Workshop: Introduction to Implementation Science
9th May 2024Online MindLabs workshop focusing on implementation science
MindLabs Workshop: Introduction to Qualitative Research Methods
4th April 2024Online MindLabs workshop focusing on qualitative research methods
MindLabs Workshop: Keeping the Co in Co-design
13th & 14th March 2024Online MindLabs workshop focusing on co-design in research
Managing cardiometabolic health for people on psychotropic medications
12th March 2024Online workshop hosted by CESPHN focusing on managing cardiometabolic health for people on psychotropic medications
MindLabs Workshop: Ethics in Lived Experience Research
11th March 2024Online MindLabs workshop focusing on ethics in lived experience research
Brings together the strengths of four founding organisations